NCT01154816 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Not reported
- Other-event reporting threshold
- 0%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Recurrent Neuroblastoma With Measurable Disease at Enrollment | 7 / 20 | 15 / 20 | Not reported / Not reported |
| Recurrent Neuroblastoma Only MIBG Evaluable Disease at Enroll | 5 / 12 | 11 / 12 | Not reported / Not reported |
| Previously Treated Childhood Rhabdomyosarcoma | 4 / 10 | 8 / 10 | Not reported / Not reported |
| Recurrent Osteosarcoma | 7 / 10 | 9 / 10 | Not reported / Not reported |
| Recurrent Ewing Sarcoma /Peripheral Neuroectodermal Tumor | 5 / 10 | 9 / 10 | Not reported / Not reported |
| Recurrent Childhood Soft Tissue Sarcoma | 3 / 8 | 6 / 8 | Not reported / Not reported |
| Childhood Hepatoblastoma | 6 / 6 | 3 / 6 | Not reported / Not reported |
| Recurrent Childhood Germ Cell Tumor | 1 / 7 | 5 / 7 | Not reported / Not reported |
| Recurrent Wilms Tumor and Other Childhood Kidney Tumors | 3 / 10 | 9 / 10 | Not reported / Not reported |
| Recurrent Childhood Acute Lympohblastic Leukemia | 8 / 10 | 10 / 10 | Not reported / Not reported |
| Recurrent Childhood Acute Myeloid Leukemia | 5 / 11 | 9 / 11 | Not reported / Not reported |
| Rhaboid Malignancy | 2 / 4 | 2 / 4 | Not reported / Not reported |
Serious adverse events
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Abdominal pain
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Activated partial thromboplastin time prolonged
- organ System
- Psychiatric disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Agitation
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Alanine aminotransferase increased
- organ System
- Immune system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Allergic reaction
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Anemia
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Anorectal infection
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Aspartate aminotransferase increased
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Back pain
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Blood bilirubin increased
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Bone pain
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Cardiac disorders - Other, specify
Other reported adverse events
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 4
- term
- Abdominal distension
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 4
- term
- Abdominal pain
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Activated partial thromboplastin time prolonged
- organ System
- Renal and urinary disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Acute kidney injury
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Alanine aminotransferase increased
- organ System
- Skin and subcutaneous tissue disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 4
- term
- Alopecia
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Anal mucositis
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 9
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 5
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 6
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 7
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 7
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 2
- num At Risk
- 4
- term
- Anemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 4
- term
- Anorexia
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Aspartate aminotransferase increased
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Back pain
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 2
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Blood bilirubin increased
Complete source fields
- event Groups
- description
- Experimental: Arm 1
- id
- EG000
- other Num Affected
- 15
- other Num At Risk
- 20
- serious Num Affected
- 7
- serious Num At Risk
- 20
- title
- Recurrent Neuroblastoma With Measurable Disease at Enrollment
- description
- Experimental: Arm 2
- id
- EG001
- other Num Affected
- 11
- other Num At Risk
- 12
- serious Num Affected
- 5
- serious Num At Risk
- 12
- title
- Recurrent Neuroblastoma Only MIBG Evaluable Disease at Enroll
- description
- Experimental: Arm 3
- id
- EG002
- other Num Affected
- 8
- other Num At Risk
- 10
- serious Num Affected
- 4
- serious Num At Risk
- 10
- title
- Previously Treated Childhood Rhabdomyosarcoma
- description
- Experimental: Arm 4
- id
- EG003
- other Num Affected
- 9
- other Num At Risk
- 10
- serious Num Affected
- 7
- serious Num At Risk
- 10
- title
- Recurrent Osteosarcoma
- description
- Experimental: Arm 5
- id
- EG004
- other Num Affected
- 9
- other Num At Risk
- 10
- serious Num Affected
- 5
- serious Num At Risk
- 10
- title
- Recurrent Ewing Sarcoma /Peripheral Neuroectodermal Tumor
- description
- Experimental: Arm 6
- id
- EG005
- other Num Affected
- 6
- other Num At Risk
- 8
- serious Num Affected
- 3
- serious Num At Risk
- 8
- title
- Recurrent Childhood Soft Tissue Sarcoma
- description
- Experimental: Arm 7
- id
- EG006
- other Num Affected
- 3
- other Num At Risk
- 6
- serious Num Affected
- 6
- serious Num At Risk
- 6
- title
- Childhood Hepatoblastoma
- description
- Experimental: Arm 8
- id
- EG007
- other Num Affected
- 5
- other Num At Risk
- 7
- serious Num Affected
- 1
- serious Num At Risk
- 7
- title
- Recurrent Childhood Germ Cell Tumor
- description
- Experimental: Arm 9
- id
- EG008
- other Num Affected
- 9
- other Num At Risk
- 10
- serious Num Affected
- 3
- serious Num At Risk
- 10
- title
- Recurrent Wilms Tumor and Other Childhood Kidney Tumors
- description
- Experimental: Arm 10
- id
- EG009
- other Num Affected
- 10
- other Num At Risk
- 10
- serious Num Affected
- 8
- serious Num At Risk
- 10
- title
- Recurrent Childhood Acute Lympohblastic Leukemia
- description
- Experimental: Arm 11
- id
- EG010
- other Num Affected
- 9
- other Num At Risk
- 11
- serious Num Affected
- 5
- serious Num At Risk
- 11
- title
- Recurrent Childhood Acute Myeloid Leukemia
- description
- Experimental: 12
- id
- EG011
- other Num Affected
- 2
- other Num At Risk
- 4
- serious Num Affected
- 2
- serious Num At Risk
- 4
- title
- Rhaboid Malignancy
- frequency Threshold
- 0
- other Events
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 4
- term
- Abdominal distension
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 4
- term
- Abdominal pain
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Activated partial thromboplastin time prolonged
- organ System
- Renal and urinary disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Acute kidney injury
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Alanine aminotransferase increased
- organ System
- Skin and subcutaneous tissue disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 4
- term
- Alopecia
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Anal mucositis
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 9
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 5
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 6
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 7
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 7
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 2
- num At Risk
- 4
- term
- Anemia
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 4
- term
- Anorexia
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Aspartate aminotransferase increased
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Back pain
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 2
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 2
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Blood bilirubin increased
- serious Events
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Abdominal pain
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Activated partial thromboplastin time prolonged
- organ System
- Psychiatric disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Agitation
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Alanine aminotransferase increased
- organ System
- Immune system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Allergic reaction
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Anemia
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Anorectal infection
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Aspartate aminotransferase increased
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Back pain
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Blood bilirubin increased
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Bone pain
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 20
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 12
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 8
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 7
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 10
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 11
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 4
- term
- Cardiac disorders - Other, specify
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle